Biogen Pharmachem Industries Ltd. has submitted its compliance certificate to the BSE for the quarter ending March 31, 2026. The filing adheres to SEBI regulations, specifically concerning depositories and participants.
Registrar Satellite Corporate Services Pvt. Ltd. confirmed in the certificate that no physical share certificates were processed for dematerialization during this period. This is a standard procedural confirmation that reassures stakeholders about the company's adherence to modern trading practices and regulatory oversight.
Established in 1995 and headquartered in Rajkot, India, Biogen Pharmachem Industries Ltd. operates in the trading of shares and securities. The company has a history of submitting these quarterly compliance reports, consistently affirming the non-receipt of physical certificates for dematerialization.
These regular filings underscore Biogen Pharmachem's commitment to regulatory compliance and reflect the broader industry trend towards fully electronic shareholding. For investors, timely submission of such reports serves as a key indicator of corporate governance.
